Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745662 · ClinicalTrials.gov registry record
Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17)
A clinical trial, sponsored by Nihon Kohden.
- Completed
- Registry status
- 11
- Enrollment target
NCT05745662: Completed study, sponsored by Nihon Kohden.
NCT05745662 is a clinical trial that has completed, run by Nihon Kohden. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05745662 has completed, sponsored by Nihon Kohden.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest.
Primary Outcome
Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter (SpO2i) to that obtained from a blood sample (SRi) and calculating the arithmetic root mean square (Arms) error value as follows: Arms =Square root (sum of n samples of ((SpO2i - SRi) squared) / n)
Interventions
- DEVICE Pulse Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-01-26 |
| Est. Completion | 2024-04-17 |
What the finished NCT05745662 record still lists
NCT05745662 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse Oximeter is the first listed.
NCT05745662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05745662 about?
NCT05745662 is a clinical study titled "Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17)". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest.
What is the current status of trial NCT05745662?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2023-01-26. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT05745662?
The interventions under investigation include: Pulse Oximeter (DEVICE).
Who is sponsoring clinical trial NCT05745662?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI